Terns Pharmaceuticals (TERN) Financials

$52.95

$52.15 (6,518.75%)

As on 15-May-2026 16:00EDT

Market cap

$6,117 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	--	--	--	1.00	--
Cost of Revenue	--	--	0.88	1.03	0.51	0.39
Gross Profit	--	--	-0.88	-1.03	1.00	-0.39
Operating Expenses	110.12	101.87	102.56	62.03	50.86	37.03
Operating Profit (EBIT)	-110.12	-101.87	-102.56	-62.03	-49.86	-37.03
Other Income	--	--	--	2.04	--	--
Profit before Tax	-95.63	-88.59	-89.97	-59.99	-49.65	-29.06
Provision for Tax	0.58	0.26	0.24	0.36	0.51	0.81
Profit after Tax (Net Income)	-96.21	-88.85	-90.21	-60.35	-50.16	-29.35
Minority Interest	--	--	--	--	--	0.52
Consolidated Profit	--	--	--	-60.35	-50.16	-29.35

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	1,006.52	345.87	255.37	276.94	160.30	68.59
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.14	2.41	1.21	1.62	0.95	0.88
Current Liabilities	16.41	15.65	11.94	8.47	6.82	22.82
Total Liabilities	1,025.08	363.93	268.52	287.03	168.07	92.29

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.88	1.82	1.09	1.84	1.14	1.42
Current Assets	1,024.19	362.11	267.43	285.19	166.93	90.87
Total Assets	1,025.08	363.93	268.52	287.03	168.07	92.29
Total Debt*	0.92	1.35	0.60	1.21	--	12.88
Net Current Assets	1,007.78	346.46	255.49	276.72	160.11	68.05

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-82.18	-70.02	-67.39	-49.11	-41.83	-29.81
Cash Flow from Investing Activities	-298.04	-12.41	-37.99	-22.27	-119.70	6.69
Cash from Financing Activities	743.51	164.00	41.95	167.10	134.39	85.52
Net Cash Inflow / Outflow	--	--	--	95.71	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.03	-0.97	-1.25	-1.10	-1.99	-1.17
Cash EPS ($)	-1.03	-0.96	-1.23	-1.08	-1.96	-1.15
Adjusted Book Value ($)	10.80	3.79	3.53	5.06	6.34	2.73
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.88	-0.77	-0.93	-0.90	-1.66	-1.19
Free Cash Flow per Share ($)	-0.88	-0.77	-0.93	-0.90	-1.67	-1.21

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-14.20	-29.46	-33.78	-27.53	-41.49	-68.52
ROE (%)	-14.23	-29.56	-33.89	-27.60	-43.83	-80.64
ROA (%)	-13.85	-28.10	-32.48	-26.52	-38.53	-50.52
EBIT Margin (%)	--	--	--	--	-4,986.00	--
Net Margin (%)	--	--	--	-2,955.19	-5,015.80	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	-1.00	--	--
EBIT Growth (%)	--	0.67	-65.34	-24.41	-34.67	46.22
Net Profit Growth (%)	-8.28	1.50	-49.49	-20.31	-70.88	57.35
EPS Growth (%)	-0.06	0.22	-0.13	0.44	-0.70	0.59
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-39.12	-5.69	-5.20	-9.23	-3.56	--
Price / Book Value	3.74	1.46	1.84	2.01	1.11	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-24.93	-1.47	-2.03	-4.51	-0.26	--
Close Price ($)	40.40	5.54	6.49	10.18	7.07	--
High Price ($)	48.26	11.40	14.04	10.25	28.36	--
Low Price ($)	1.87	4.32	3.26	1.45	5.52	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	0.00	0.00	0.00	0.00	--	0.19
Short term debt to equity ratio	0.00	0.00	0.00	0.00	--	0.19
Current Ratio	62.41	23.14	22.39	33.68	24.48	3.98
Quick Ratio	--	--	--	--	--	3.85
Interest Coverage	--	--	--	-30.38	-69.06	-16.72

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	0.01	--
Receivable days	--	--	--	--	4,645.25	--
Inventory Days	--	--	--	--	2,115.88	2,749.57
Payable days	--	--	862.34	667.32	1,091.83	1,191.70
Cash Conversion Cycle	--	--	--	--	5,669.30	--